Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CXCR3 | P49682 | 3/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.35 |
| ▸ | CDK2 | P24941 | 2/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.35 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SYK | P43405 | 2/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | LIPE | Q05469 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6170501 | 0.92 | LMNA (0.42) | LMNAPOLBL3MBTL1CXCR3LIPE | |
| SCHEMBL6174458 | 0.88 | SLC5A1 (0.40) | LMNAPOLBL3MBTL1CXCR3LIPE | |
| SCHEMBL6173353 | 0.88 | LMNA (0.45) | LMNAPOLBL3MBTL1CXCR3LIPE | |
| SCHEMBL6176663 | 0.86 | LMNA (0.39) | LMNAPOLBL3MBTL1CXCR3NPC1 | |
| SCHEMBL6173052 | 0.86 | EPHX2 (0.36) | LMNAPOLBL3MBTL1CXCR3LIPE | |
| SCHEMBL6175577 | 0.85 | EPHX2 (0.40) | LMNALIPE | |
| SCHEMBL6173172 | 0.85 | LMNA (0.41) | LMNAL3MBTL1NPC1RAB9AMAPT | |
| SCHEMBL6173161 | 0.85 | IGF1R (0.37) | LMNASIRT3TDP1 | |
| SCHEMBL6251397 | 0.85 | EPHX2 (0.39) | LMNALIPE | |
| SCHEMBL6173698 | 0.85 | LMNA (0.42) | LMNAPOLBL3MBTL1CXCR3LIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |